| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $212,693 ) |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI174181 | Development and function of skin-resident innate-like T cells at early postnatal stages | 001 | 2 | NIH | 11/12/2024 | $54,277 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI174181 | Development and function of skin-resident innate-like T cells at early postnatal stages | 000 | 2 | NIH | 11/6/2024 | $461,158 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA286307 | Development of Caspase Cleavage Targeting Chimeras (CACTACs) for Targeted Protein Cleavage | 000 | 2 | NIH | 11/1/2024 | $194,387 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R03AG086958 | Pathological cardiolipin remodeling links mitochondrial dysfunction to inflammaging | 000 | 1 | NIH | 11/13/2024 | $78,750 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | T32HL007446 | Pathobiology of Occlusive Vascular Disease | 000 | 43 | NIH | 11/11/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01CA263981 | A Testing Program to Identify Novel Agents for Treatment of Pediatric and AYA High-Risk Sarcoma, Kidney and Liver Cancer | 000 | 4 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG069740 | The Paternal Age Effect - Enhanced Germ Cell Mutagenesis Modulated by the TRP53/APE1/MDM2 Tumor Suppressor Axis | 000 | 5 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HG013258 | Hormonal Influences on Inflammation in Endometriosis | 000 | 1 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HG013258 | Hormonal Influences on Inflammation in Endometriosis | 000 | 1 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00DE031784 | Specialized Proresolving Lipid Mediator-Enhanced Stem Cell Therapy and Tissue Regeneration | 000 | 3 | NIH | 10/22/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32AA031898 | Mechanisms by which alcohol disrupts astrocytic control of neuronal excitability | 002 | 2 | NIH | 10/24/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32AA031898 | Mechanisms by which alcohol disrupts astrocytic control of neuronal excitability | 001 | 2 | NIH | 10/24/2024 | $73,408 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD114855 | Disentangling the genetic mechanisms of endometriosis severity with single-cell multi-omics | 000 | 1 | NIH | 10/10/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA257391 | PAI-1-mediated early-onset endometrial cancer | 000 | 4 | NIH | 10/10/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | 90AK0095 | Empowering Futures: Promoting Life Skills for Underserved Communities | 01 | 1 | ACF | 10/8/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | D3449235 | Centers of Excellence | 01 | 2 | HRSA | 11/2/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | D8545711 | Predoctoral Training in General, Pediatric, and Public Health Dentistry and Dental Hygiene | 01 | 3 | HRSA | 11/7/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | D8545711 | Predoctoral Training in General, Pediatric, and Public Health Dentistry and Dental Hygiene | 01 | 3 | HRSA | 11/7/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | D8545711 | Predoctoral Training in General, Pediatric, and Public Health Dentistry and Dental Hygiene | 01 | 3 | HRSA | 11/7/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | D8545711 | Predoctoral Training in General, Pediatric, and Public Health Dentistry and Dental Hygiene | 01 | 3 | HRSA | 11/7/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | D8837558 | Postdoctoral Training in General, Pediatric and Public Health Dentistry and Dental Hygiene | 03 | 5 | HRSA | 10/24/2024 | $0 |
| | 2025 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | D8837558 | Postdoctoral Training in General, Pediatric and Public Health Dentistry and Dental Hygiene | 03 | 5 | HRSA | 10/24/2024 | $0 |
| | 2025 | 2023 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM137009 | Novel Coregulators of Estrogen Receptor in Enhancer-regulated Transcription | 000 | 4 | NIH | 11/14/2024 | $0 |
| | 2025 | 2023 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL158081 | Role of BRD4 in Normal Hematopoiesis and Hematopoietic Stem Cell Biology | 000 | 2 | NIH | 10/30/2024 | $0 |
| | 2025 | 2022 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS102448 | Opposing Roles for Microglia in the Young and Aged Neurogenic Niche | 000 | 5 | NIH | 11/12/2024 | -$923 |
| | 2025 | 2022 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH117101 | Cognitive Adaptation Training: Effectiveness in real-world settings and Mechanisms of Action (CAT-EM) | 000 | 5 | NIH | 10/16/2024 | -$98,942 |
| | 2025 | 2022 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21DE031089 | Integrating periodontitis assessment in medical research using computationallyenhanced classification | 000 | 1 | NIH | 10/22/2024 | -$132,950 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AA025128 | Ethanol and brain state-dependent neural signaling | 000 | 5 | NIH | 11/1/2024 | $0 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG057431 | Primary fibroblast resiliency as a predictor of health and lifespan in mice | 000 | 5 | NIH | 10/11/2024 | -$16,302 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG067164 | Feasibility of a novel nonhuman primate model of age-related nonalcoholic fatty liver disease | 000 | 2 | NIH | 10/10/2024 | -$3,045 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE029187 | LIGHT and Lymphotoxin targeting for the treatment of chronic orofacial pain conditions | 000 | 1 | NIH | 10/1/2024 | -$143,413 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG068731 | An innovative proof-of-concept approach to identify age-modulating drugs capable of reversing inflammation and re-setting the epigenetic clock | 000 | 2 | NIH | 10/15/2024 | -$1,759 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA205965 | (PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration | 000 | 5 | NIH | 10/11/2024 | -$9,414 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL137703 | Combination of PPI and pirfenidone to enhance antifibrotic efficacy | 002 | 6 | NIH | 10/17/2024 | $241,149 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL137703 | Combination of PPI and pirfenidone to enhance antifibrotic efficacy | 003 | 6 | NIH | 11/12/2024 | -$348,095 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01TR002393 | Harnessing the power of CTSA-CDRN data networks: Using social determinants of health, frailty and functional status to identify at-risk patients and improve risk adjustment | 000 | 4 | NIH | 11/14/2024 | -$2,295 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01TR002393 | Harnessing the power of CTSA-CDRN data networks: Using social determinants of health, frailty and functional status to identify at-risk patients and improve risk adjustment | 000 | 4 | NIH | 11/14/2024 | -$14,917 |
| | 2025 | 2021 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA026868 | Consequences of Substance Use on the Development of Impulse Control | 000 | 10 | NIH | 11/6/2024 | $0 |
| | 2025 | 2020 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK121527 | Hepatokine Control of Metabolic Crosstalk and Insulin Resistance | 000 | 2 | NIH | 11/14/2024 | -$122 |
| | 2025 | 2019 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA038645 | KOR Agonist Functional Selectivity in Peripheral Sensory Neurons | 000 | 4 | NIH | 10/1/2024 | -$52,493 |
| | 2025 | 2019 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS094461 | Targeting specific interactions between A-kinase Anchoring Proteins (AKAPs) and ion channels with cell-permeant peptides as a novel mode of therapeutic intervention against pain disorders | 000 | 4 | NIH | 10/1/2024 | -$10,846 |
| | 2025 | 2019 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | RF1AG058778 | Regulation of ER-stress Activated UPR kinase PERK in Neurodegenerative Diseases | 000 | 1 | NIH | 10/1/2024 | -$268 |
| | 2025 | 2019 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | RF1AG063507 | Plasma Proteome and Risk of Alzheimer Dementia and Related Endophenotypes in the Framingham Study | 000 | 2 | NIH | 10/1/2024 | -$54,651 |
|
| Issue Date FY: 2024 ( Subtotal = $145,831,501 ) (Continued on the next page) |
| | 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25DK121576 | San Antonio Program for Undergraduate Research in Renal Science (SPURRS) | 001 | 6 | NIH | 2/14/2024 | $117,629 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133304 | A novel pathway controls liver injury in NASH | 000 | 3 | NIH | 5/6/2024 | $501,032 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG075703 | Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease | 000 | 3 | NIH | 3/14/2024 | $582,280 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 Floyd Curl Drive | San Antonio | TX | 78229-3901 | BEXAR | USA | T0830150 | Scholarships for Disadvantaged Students | 01 | 9 | HRSA | 8/8/2024 | $20,000 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | T0830150 | Scholarships for Disadvantaged Students | 00 | 9 | HRSA | 5/24/2024 | $650,000 |
|
